Stifel Financial Targets $1 Trillion in Wealth Management Assets

Published 18 hours agoSF

Stifel Financial Targets $1 Trillion in Wealth Management Assets

Stifel Financial is making significant strides in expanding its wealth management division with a goal to manage $1 trillion in client assets. The brokerage firm plans to achieve this milestone through strategic recruiting and acquisitions, while simultaneously enhancing its technology capabilities to expand product offerings and improve client services.

The financial services company is also bolstering its banking operations by focusing on growth in client and corporate deposits. As part of its growth strategy, Stifel is utilizing its financial services holding company status to drive loan growth, leveraging the strength of the Stifel franchise. According to sources, the company remains optimistic about long-term growth despite current market uncertainties, highlighting its advice-driven model as a key asset.

Stifel is committed to enhancing operational efficiencies within its Institutional Group by increasing market share through strategic hiring and targeted acquisitions. The company continues to prioritize risk management, aiming for risk-adjusted returns in its capital deployment strategies. Executives maintain a focus on sustainable growth, reinforcing the company's resilience in the face of market challenges.

Share this article

Twitter Facebook LinkedIn

Recent Articles

L3Harris Reports Mixed Q1 2025 Results, Lowers Revenue Forecast

L3Harris Reports Mixed Q1 2025 Results, Lowers Revenue Forecast

14 minutes agoLHX

L3Harris Technologies announced its Q1 2025 financial results, revealing revenue figures between $5.1 billion and $5.13 billion, which fell short of analysts' expectations of $5.22 billion. However, the company delivered a non-GAAP EPS of $2.41, exceeding the anticipated $2.32, while GAAP EPS came in at $2.04. According to Insider Monkey, L3Harris revised its full-year revenue guidance down to a range of $21.4 billion to $21.7 billion, citing divestitures and necessary operational adjustments as contributing factors. The company also returned $797 million to shareholders, distributing $228 million in dividends and repurchasing shares worth $569 million. Meanwhile, the adjusted segment operating margin expanded to 15.6%, despite a decline in the book-to-bill ratio to 0.84x. CEO Christopher Kubasik highlighted the company's focus on operational execution and its commitment to aligning with national security priorities. However, these updates led to a premarket share decline of approximately 1% to 1.5%, as investors reacted to the revenue miss and downward-revised outlook.

Uber Teams Up with Volkswagen for Autonomous Fleet Rollout

Uber Teams Up with Volkswagen for Autonomous Fleet Rollout

29 minutes agoUBER

Uber and Volkswagen have forged a strategic partnership to bring autonomous ID. Buzz minivans to Uber's ride-hailing platform. This collaboration intends to integrate thousands of these electric vehicles across several U.S. cities, marking a significant step in Uber's push towards autonomous transportation. The initiative will kick off with an initial deployment in Los Angeles, with trials expected in 2025, leading to a commercial launch in 2026. During the initial phase, the vehicles will feature safety drivers to monitor operations. According to Electrek, MOIA, Volkswagen AG's autonomous mobility brand, will be responsible for providing the autonomous vehicle technology. Volkswagen's autonomous ID. Buzz vehicles are tailored differently from consumer models, potentially accommodating up to four passengers along with luggage. The partnership aims to integrate these robotaxis with Uber's traditional fleet of human-driven cars. As part of its long-term vision, Volkswagen plans to extend its autonomous vehicle services to 50 cities in North America and Europe by 2030.

UPS Acquires Canadian Healthcare Logistics Firm for $1.6 Billion

UPS Acquires Canadian Healthcare Logistics Firm for $1.6 Billion

44 minutes agoUPS

United Parcel Service (UPS) has announced a definitive agreement to acquire Andlauer Healthcare Group (AHG), a Canadian-based specialized healthcare logistics company, for approximately $1.6 billion USD (CAD $2.2 billion). This move is targeted at expanding UPS Healthcare's capabilities in cold chain logistics, a critical area in the transportation of temperature-sensitive healthcare products. According to Insider Monkey, the acquisition will provide UPS with AHG's advanced temperature-controlled facilities and specialized transportation solutions designed specifically for the healthcare sector. AHG shareholders are set to receive CAD $55 per share in cash as part of the agreement. The transaction awaits approval from AHG shareholders and regulatory bodies, and it is anticipated to close in the latter half of 2025. Michael Andlauer, the founder and CEO of AHG, along with the controlling shareholder, the Andlauer Management Group, have already pledged their support for the acquisition. Post-transaction, Mr. Andlauer will lead the combined entity's efforts as the head of UPS Canada Healthcare, aiming to reinforce UPS's strategic mission to be a leader in complex healthcare logistics and address the global demands for next-generation treatments.

West Pharmaceutical Services Declares Consistent Dividend Payouts

West Pharmaceutical Services Declares Consistent Dividend Payouts

59 minutes agoWST

West Pharmaceutical Services, Inc. has announced a second-quarter dividend of $0.21 per share, scheduled for payment on May 7, 2025, to shareholders on record as of April 30, 2025. The company also plans to distribute a third-quarter dividend of the same amount, payable on August 6, 2025, to shareholders recorded by July 30, 2025. In recent financial disclosures, West Pharmaceutical Services reported a significant increase in free cash flow, rising to $58.1 million from $27.6 million the previous year. This robust financial performance underscores the company's upward trajectory, which also includes heightened adjusted diluted earnings per share guidance, as noted by sources such as Insider Monkey. The company's unwavering commitment to shareholder returns is evident through its impressive track record of sustained dividend payments for 53 years and consistent annual increases over the past 32 years. As a distinguished player within the pharmaceutical sector, West Pharmaceutical Services continues to reinforce its industry position by producing over 41 billion components annually and maintaining its status in the S&P 500 index.